The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $24.32 in the prior trading day, Insmed Inc (NASDAQ: INSM) closed at $24.11, down -0.86%. In other words, the price has decreased by $-0.86 from its previous closing price. On the day, 3.28 million shares were traded. INSM stock price reached its highest trading level at $25.145 during the session, while it also had its lowest trading level at $23.55.
Ratios:
Our goal is to gain a better understanding of INSM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.75 and its Current Ratio is at 4.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on February 15, 2024, initiated with a Outperform rating and assigned the stock a target price of $42.
On December 08, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $55.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 12 ’24 when Adsett Roger sold 5,251 shares for $28.63 per share. The transaction valued at 150,336 led to the insider holds 148,559 shares of the business.
Flammer Martina M.D. sold 4,667 shares of INSM for $133,616 on Jan 12 ’24. The Chief Medical Officer now owns 106,898 shares after completing the transaction at $28.63 per share. On Jan 10 ’24, another insider, Adsett Roger, who serves as the Chief Operating Officer of the company, sold 3,536 shares for $28.90 each. As a result, the insider received 102,190 and left with 153,810 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSM now has a Market Capitalization of 3581661440 and an Enterprise Value of 4189896192. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.73. Its current Enterprise Value per Revenue stands at 13.728 whereas that against EBITDA is -6.23.
Stock Price History:
Over the past 52 weeks, INSM has reached a high of $32.00, while it has fallen to a 52-week low of $17.41. The 50-Day Moving Average of the stock is -11.93%, while the 200-Day Moving Average is calculated to be -6.27%.
Shares Statistics:
The stock has traded on average 1.67M shares per day over the past 3-months and 2003150 shares per day over the last 10 days, according to various share statistics. A total of 147.98M shares are outstanding, with a floating share count of 144.65M. Insiders hold about 2.59% of the company’s shares, while institutions hold 101.16% stake in the company. Shares short for INSM as of 1711584000 were 9041518 with a Short Ratio of 5.43, compared to 1709164800 on 8574607. Therefore, it implies a Short% of Shares Outstanding of 9041518 and a Short% of Float of 6.18.
Earnings Estimates
A comprehensive evaluation of Insmed Inc (INSM) is underway, with the input of Inseego Corp. analysts contributing to its current rating.The consensus estimate for the next quarter is $24.11, with high estimates of $53.60 and low estimates of $225.22.
